Cancer Biomarker Discovery and Assay Development 2014

Whilst numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers are already being used at some point in patient care. This event will discuss the further discovery and assay development of genetic, epigenetic, proteomic, glycomic, and imaging biomarkers which can be used for cancer diagnosis, prognosis, and epidemiology. We provide an informal atmosphere for discussion and debate. This is an ideal setting for experts to present their work and discuss their findings

Who Should Attend
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers

Speakers Include:
Dr Massimo Pancione, PhD Researcher of Molecular Biology, University of Sannio, Italy